Effects of 180 μg and 250 μg norgestimate on pituitary-ovarian function and cervical mucus
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 50 (5) , 756-760
- https://doi.org/10.1016/s0015-0282(16)60311-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucusAdvances in Contraception, 1986
- Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen‐only oral contraceptionBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterusContraception, 1985
- A Standardised Multicentre Procedure for Plasma Gonadotrophin RadioimmunoassayAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
- The Analysis of Unbalanced Cross-ClassificationsJournal of the Royal Statistical Society. Series A (General), 1978
- The pharmacological profile of norgestimate, a new orally active progestinContraception, 1977
- THE EFFECT OF DAILY NORETHISTERONE (0.35 mg) ON CERVICAL MUCUS AND ON URINARY LH, PREGNANEDIOL AND OESTROGEN LEVELSBJOG: An International Journal of Obstetrics and Gynaecology, 1976
- Serum LH Concentration in Women under Contraceptive Treatment with Estrogen-Free ProgestagensHormone and Metabolic Research, 1973
- The Cervical ScoreInternational Journal of Gynecology & Obstetrics, 1972